tiprankstipranks

Jeffrey Keyser Insider Profile

4 Followers
Jeffrey Keyser, COO at ZS Pharma, holds 0.00 shares in Lantern Pharma (Ticker: LTRN), holds 0.00 shares in ZS Pharma (Ticker: ZSPH). Most recently, Jeffrey Keyser Bought ― shares of Lantern Pharma on Jul 26, 2024 for an estimated value of 11.99K.
tipranks
Jeffrey Keyser

Jeffrey Keyser
ZS Pharma (ZSPH)
COO

Ranked #55,188 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-6.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Jeffrey Keyser does not currently own shares as a corporate insider.
A breakdown of Jeffrey Keyser's holdings

Insider Roles

Lantern Pharma
(LTRN)
Director
Roles that Jeffrey Keyser holds in companies

Most Profitable Insider Trade

Stock:
Lantern Pharma
(LTRN)
Rating:Informative Buy
Date:Jun 15, 2020 - Jun 15, 2021
Return:+2.60%
The most profitable trade made by Jeffrey Keyser

Jeffrey Keyser's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ZSPH
ZS Pharma
Dec 21, 2015
Uninformative Sell
1.11M
$0.00
Lantern Pharma
Jul 26, 2024
Director
Informative Buy
11.99K
$0.00
List of latest transactions for each holding click on a transaction to see Jeffrey Keyser's performance on stock

Jeffrey Keyser insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Keyser?
The percentage of profitable transactions made by Jeffrey Keyser is 50%.
    What is the average return per transaction made by Jeffrey Keyser?
    The average return per transaction made by Jeffrey Keyser is -6.70%.
      What stocks does Jeffrey Keyser hold?
      Jeffrey Keyser holds: ZSPH, LTRN stocks.
        What was Jeffrey Keyser’s latest transaction?
        Jeffrey Keyser latest transaction was an Informative Buy of $11.99K.
          What was Jeffrey Keyser's most profitable transaction?
          Jeffrey Keyser’s most profitable transaction was an Informative Buy of LTRN stock on June 15, 2020. The return on the trade was 2.60%.
            What is Jeffrey Keyser's role in ZS Pharma?
            Jeffrey Keyser's role in ZS Pharma is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.